Synaptopathy - From Biology to Therapy

25th Neuropharmacology Conference 2015

15 - 16 October 2015 | The Westin Chicago River North,
Chicago, USA | Official Satellite Meeting to Society for Neuroscience

  • Register by 11 September to claim your early bird deadline! Register here »

The 25th Neuropharmacology Conference 2015 will be held in Chicago, USA from 15-16 October 2015, under the theme: Synaptopathy - From biology to therapy.

Synaptic pathology has recently been recognized as a common feature in a wide variety of childhood and adult brain diseases, including Alzheimer’s.

Bridging the gaps in our understanding of the basic biology of synapses, the causes of synaptopathy and the challenges in developing novel therapeutic approaches will be the goal of the meeting.

The program will showcase academic and industry scientists tackling fundamental molecular mechanisms, drug discovery, animal models and clinical studies.

Conference Topics:

  • Synapse types and the pre- and post-synaptic terminal
  • Childhood diseases – autism and intellectual disability
  • Schizophrenia and other young adult onset diseases
  • Synaptopathy in neurodegenerative diseases and ageing
  • Addiction, brain injury, excitotoxicity and toxic insults
  • Challenges in translating therapies from mouse to human
  • Human synapses and iPS neurons
Register Now Submit Abstract View Program

Click to download apps


Conference Co-Chairs

  • Claudia Bagni, VIB Center for the Biology of Disease, KU Leuven, Belgium & University of Rome Tor Vergata, Italy
  • Seth G.N. Grant, Centre for Clinical Brain Sciences, University of Edinburgh, UK
  • Thomas J. O’Dell, David Geffen School of Medicine, University of California, Los Angeles, USA

    Keynote Speakers

  • Thomas Südhof, Stanford University, USA
  • Richard Tsien, New York University, USA
  • Invited Speakers

  • Claudia Bagni, VIB Center for the Biology of Disease, KU Leuven, Belgium & University of Rome Tor Vergata, Italy
  • Thomas Bourgeron, Institut Pasteur, France
  • Nils Brose, Max Planck Institute of Experimental Medicine, Germany
  • Ricardo Dolmetsch, Novartis Institutes for Biomedical Research, USA
  • Ron Duman, Abraham Ribicoff Research Facilities, USA
  • Daniel Geschwind, University of California, Los Angeles, USA 
  • Seth Grant, University of Edinburgh, UK
  • Cornelius Gross, European Molecular Biology Laboratory, Italy
  • Benjamin Hall, Tulane University, USA
  • Eunjoon Kim, Korea Advanced Institute of Science & Technology, South Korea
  • Eric Klann, New York University, USA
  • Malcolm MacLeod, University of Edinburgh, UK
  • Lisa Monteggia, UT Southwestern Medical Centre, USA
  • Tom O'Dell, University of California, Los Angeles, USA
  • Shigeo Okabe, University of Tokyo, Japan
  • Michael Owen, Cardiff University, UK
  • Katherine Roche, NINDS/NIH, USA
  • Gavin Rumbaugh, Scripps Florida, USA
  • Bernardo Sabatini, Harvard University, USA
  • Alcino Silva, University of California, Los Angeles, USA 
  • Beth Stevens, Harvard University, USA
  • Suzanne Zukin, Albert Einstein College of Medicine, USA
Supporting Publication
Join the Conversation

Organised by